80 related articles for article (PubMed ID: 31533472)
1. Identification of Emetine as a Therapeutic Agent for Pulmonary Arterial Hypertension: Novel Effects of an Old Drug.
Siddique MAH; Satoh K; Kurosawa R; Kikuchi N; Elias-Al-Mamun M; Omura J; Satoh T; Nogi M; Sunamura S; Miyata S; Ueda H; Tokuyama H; Shimokawa H
Arterioscler Thromb Vasc Biol; 2019 Nov; 39(11):2367-2385. PubMed ID: 31533472
[TBL] [Abstract][Full Text] [Related]
2. Dynamin-related protein 1-mediated mitochondrial mitotic fission permits hyperproliferation of vascular smooth muscle cells and offers a novel therapeutic target in pulmonary hypertension.
Marsboom G; Toth PT; Ryan JJ; Hong Z; Wu X; Fang YH; Thenappan T; Piao L; Zhang HJ; Pogoriler J; Chen Y; Morrow E; Weir EK; Rehman J; Archer SL
Circ Res; 2012 May; 110(11):1484-97. PubMed ID: 22511751
[TBL] [Abstract][Full Text] [Related]
3. Evidence for the Fucoidan/P-Selectin Axis as a Therapeutic Target in Hypoxia-induced Pulmonary Hypertension.
Novoyatleva T; Kojonazarov B; Owczarek A; Veeroju S; Rai N; Henneke I; Böhm M; Grimminger F; Ghofrani HA; Seeger W; Weissmann N; Schermuly RT
Am J Respir Crit Care Med; 2019 Jun; 199(11):1407-1420. PubMed ID: 30557519
[No Abstract] [Full Text] [Related]
4. Carbonic Anhydrase Inhibition Ameliorates Inflammation and Experimental Pulmonary Hypertension.
Hudalla H; Michael Z; Christodoulou N; Willis GR; Fernandez-Gonzalez A; Filatava EJ; Dieffenbach P; Fredenburgh LE; Stearman RS; Geraci MW; Kourembanas S; Christou H
Am J Respir Cell Mol Biol; 2019 Oct; 61(4):512-524. PubMed ID: 30951642
[TBL] [Abstract][Full Text] [Related]
5. Effect of IL-17 on pulmonary artery smooth muscle cells and connective tissue disease-associated pulmonary arterial hypertension.
Shi TY; Wen XH; Meng J; Lu YW
Immun Inflamm Dis; 2024 Apr; 12(4):e1243. PubMed ID: 38577988
[TBL] [Abstract][Full Text] [Related]
6. Serotonin and Pulmonary Hypertension; Sex and Drugs and ROCK and Rho.
MacLean MR; Fanburg B; Hill N; Lazarus HM; Pack TF; Palacios M; Penumatsa KC; Wring SA
Compr Physiol; 2022 Aug; 12(4):4103-4118. PubMed ID: 36036567
[TBL] [Abstract][Full Text] [Related]
7. Characterization of PKCα-rutin interactions and their application as a treatment strategy for pulmonary arterial hypertension by inhibiting ferroptosis.
Che H; Yi J; Zhao X; Yu H; Wang X; Zhang R; Li X; Fu J; Li Q
Food Funct; 2024 Jan; 15(2):779-793. PubMed ID: 38126185
[TBL] [Abstract][Full Text] [Related]
8. GPCRs in pulmonary arterial hypertension: tipping the balance.
Iyinikkel J; Murray F
Br J Pharmacol; 2018 Aug; 175(15):3063-3079. PubMed ID: 29468655
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic potential of natural flavonoids in pulmonary arterial hypertension: A review.
Zhang JJ; Mao-Mao ; Shao MM; Wang MC
Phytomedicine; 2024 Jun; 128():155535. PubMed ID: 38537442
[TBL] [Abstract][Full Text] [Related]
10. Novel approaches to pulmonary arterial hypertension drug discovery.
Sung YK; Yuan K; de Jesus Perez VA
Expert Opin Drug Discov; 2016; 11(4):407-14. PubMed ID: 26901465
[TBL] [Abstract][Full Text] [Related]
11. Research progress on the role of p53 in pulmonary arterial hypertension.
Liu X; Liu B; Luo X; Liu Z; Tan X; Zhu K; Ouyang F
Respir Investig; 2024 Apr; 62(4):541-550. PubMed ID: 38643536
[TBL] [Abstract][Full Text] [Related]
12. Signal transduction in the development of pulmonary arterial hypertension.
Malenfant S; Neyron AS; Paulin R; Potus F; Meloche J; Provencher S; Bonnet S
Pulm Circ; 2013 Apr; 3(2):278-93. PubMed ID: 24015329
[TBL] [Abstract][Full Text] [Related]
13. Emetine Is Not Ipecac: Considerations for Its Use as Treatment for SARS-CoV2.
Bleasel MD; Peterson GM
Pharmaceuticals (Basel); 2020 Nov; 13(12):. PubMed ID: 33261173
[TBL] [Abstract][Full Text] [Related]
14. Recent Researches on Emetine and its Value as a Therapeutic Agent in Amœbiasis and other Diseases.
Low GC
Proc R Soc Med; 1914; 7(Ther Pharmacol Sect):41-50. PubMed ID: 19978461
[No Abstract] [Full Text] [Related]
15. Recent developments on potential new applications of emetine as anti-cancer agent.
Uzor PF
EXCLI J; 2016; 15():323-8. PubMed ID: 27366142
[No Abstract] [Full Text] [Related]
16. FUT8-Mediated Core Fucosylation Promotes the Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension.
Zhang W; Lin W; Zeng X; Zhang M; Chen Q; Tang Y; Sun J; Liang B; Zha L; Yu Z
Aging Dis; 2023 Oct; 14(5):1927-1944. PubMed ID: 37196106
[TBL] [Abstract][Full Text] [Related]
17. Emetine in Combination with Chloroquine Induces Oncolytic Potential of HIV-1-Based Lentiviral Particles.
Spirin P; Shyrokova E; Vedernikova V; Lebedev T; Prassolov V
Cells; 2022 Sep; 11(18):. PubMed ID: 36139404
[TBL] [Abstract][Full Text] [Related]
18. Application of emetine in SARS-CoV-2 treatment: regulation of p38 MAPK signaling pathway for preventing emetine-induced cardiac complications.
Valipour M; Irannejad H; Emami S
Cell Cycle; 2022 Nov; 21(22):2379-2386. PubMed ID: 35852390
[TBL] [Abstract][Full Text] [Related]
19. Different Aspects of Emetine's Capabilities as a Highly Potent SARS-CoV-2 Inhibitor against COVID-19.
Valipour M
ACS Pharmacol Transl Sci; 2022 Jun; 5(6):387-399. PubMed ID: 35702393
[TBL] [Abstract][Full Text] [Related]
20. Mineralocorticoid receptor antagonist treatment of established pulmonary arterial hypertension improves interventricular dependence in the SU5416-hypoxia rat model.
Lu M; Chen LY; Gairhe S; Mazer AJ; Anderson SA; Nelson JNH; Noguchi A; Siddique MAH; Dougherty EJ; Zou Y; Johnston KA; Yu ZX; Wang H; Wang S; Sun J; Solomon SB; Vanderpool RR; Solomon MA; Danner RL; Elinoff JM
Am J Physiol Lung Cell Mol Physiol; 2022 Mar; 322(3):L315-L332. PubMed ID: 35043674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
